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A drug to suppress uterine activity with minimal
or no side eflfects would be valuable for the
prevention of premature or precipitous labor, or
for the control of tetanic uterine contractions.
Recently it has been reported that diazoxide*,
a benzothiadiazine derivative, a smooth muscle
relaxant [15] inhibits myometrial activity of the
human uterus [3, 9] with no apparent adverse
reactions on the fetus [5, 8]. However, the dose
necessary to suppres uterine activity also causes
maternal hypotension [5] and the drug has
other pharmacologic actions including the in-
duction of hyperglycemia.
Because of the lack.of direct Information on the
effect of the drug on the fetus, pilot experiments
were conducted in our laboratory on the pregnant
guinea pig and her fetus [11], Blood glucose rose
to a similar degree in both mother and fetus,
and when delivered, the fetuses were acidotic
and severely depressed, probably äs a result of
maternal hypotension. On the basis of these ob-
servations, it was feit that possible adverse
effects of the drug on the fetus should be
examined more carefully. This paper describes
experiments on pregnant subhuman primates in
which the inhibiting action of diazoxide on
uterine activity, placental transfer of the drug
and its effect on the cardiovascular and bio-
chemical state of both mother and fetus were
studied.
* Hyperstat® (Schering Corporation, USA).
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1. Material and methods
Experiments were conducted on a total of 31 pregnant
primates. These consisted of 9 rhesus monkeys (maccaca
mulatta) and 7 Java monkeys (maccaca fasicularis), at
gestational ages ranging from 132 to 155 days (term
168 days), and 15 baboons (papio hybrid) at gestational
ages ranging from 150 to 171 days (term 185 days).
Acid-base data from 42 additional pregnant primates
studied earlier are included in order to evaluate
changes in acid-base state of the fetus following the
infusion of diazoxide.
The model used has been described previously in detail [7],
Briefly, catheters were placed in the fetal carotid artery
or femoral artery and amniotic fluid at hysterotomy, and
in the maternal femoral artery and vein. In addition,
thermistor probes were placed in the fetal csophagus and
maternal rectum. Post-operatively, light sedation was
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maintained with nitrous oxide and oxygen [12]. Maternal
and fetal arterial pressure, heart rate, and amniotic fluid
pressure were monitored and recorded continuously. Fol-
lowing the operative procedure, recovery of both mother
and fetus was monitored for a period of 2 hours. During
this time, uterine contractions commenced spontaneously
in 20 animals; in 15 of these, a well-established labor
developed while in 5, the contractions remained mild äs
in early labor. In the remaining 11, uterine contractions
were induced with oxytocin (8 animals) or prostaglandin
F2oc (3 animals). Oxytocin was administered I. V. at a rate
of 5—20 milli-units per minute depending on the dose
necessary to increase uterine activity to a level comparable
to that seen during spontaneous labor. Prostaglandin F2oc
was administered I. V. at a rate of 0.3 to 0.6 mg/kg/min;
infusion rate was kept constant throughout the experiment.
The uterine activity following induced labor was
187 ± 20.2 (S. E.) Montevideo units [1], and of similar
intensity to that seen in spontaneous labor, 216 ± 19.9
(S. E.) Montevideo units. In the 5 animals where uterine
activity was comparable to early labor, the intensity of
activity was calculated to be between 90 and 120 Monte-
video units.
Diazoxide was infused intravenously into 21 animals while
isotonic saline was infused into the remaining 10, which
formed the control group. The infusion was begun at the
end of the recovery period \vhen either spontaneous or
induced labor was well-established. The diazoxide Solutions
were made from Hyperstat® (Schering Corporation, USA)
(supplied in 20 ml ampules in a concentration of 15 mg/ml)
which was diluted to 2 mg/ml in isotonic saline.
The drug was administered in three ways: (a) in
a graded dose to determine dose response,
group I, 10 animals, tab. 1; (b) äs a bolus in an
attempt to suppress uterine activity acutely,
group II, 6 animals, tab. 2 (this is the technique
which has been used clinically in humans); (c) in
a low dosage äs a slow, prolonged infusion in
the 5 animals with only mild uterine activity,
group III, tab. 3. In group I, diazoxide was in-
fused for approximately 60 minutes, the dose
ranging from 6.2 to 62.7 mg/kg with an infusion
rate of 0.11 to 1.10 mg/kg/min; the lowest dose
was chosen since it was similar to that given in
clinical investigation of pregnant humans [5, 8].
For group II, 6 mg/kg was given äs a bolus. In
group III, a 1% solution of diazoxide was ad-
ministered for a period of 4—7 hours, total dose
ranging from 180 to 300 mg with an infusion
rate of 0.043^—0.057 mg/kg/min. In the 10 animals
which formed group IV (control) isotonic saline
was infused at a comparable rate to the infusion
given to the diazoxide group.
Blood samples were withdrawn from arterial catheters
periodically throughout the experiment for determination
of pH, PCO? and Po2 using Radiometer microelectrodes.
The base deficit was calculated by means of the Radiometer
blood gas calculator. Blood was obtained from the maternal
and fetal arteries for glucose determination in 14 experi-
ments and for measurement of diazoxide concentration in
9 experiments. Glucose content was measured by the
glücose^oxidase method; diazoxide concentration was
determined by a modification of the method described
by CALESNICK [2]. Warm maternal blood, drawn prior
to the study, was periodically replaced into the fetal
circulation following fetal blood sampling.
2. Results
2.1 Uterine Activity
There was a reduction in the intensity of uterine
activity within a few minutes,, of commencing
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Fig. 1. Effect of a continuous infusion of diazoxide on uterine activity, blood pressure and heart rate of mother
and fetus. Note the disappearance of late deceleration of the fetal heart rate with cessation of uterine contractions.
(Animal J19, tab. 1).
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the diazoxide Infusion (fig. 1) and within 30 min-
utes, activity was suppressed 50% in all but one
animal, irrespective of whether labor was spon-
taneous or induced (tab. 1). The time to respond
was somewhat variable. Following the termination
of diazoxide, sustained Inhibition continued for
30 minutes or longer and in those animals receiv-
ing the largest dose, the inhibiting action lasted
for over 2 hours. In the second group of animals
receiving the bolus injection of diazoxide,
Tab. 1. Effect of I. V. Infusion of diazoxide on uterine activity (Group I).
Animal Gestation Type Diazoxide
(days) of Labor Total dose Infusion rate
(mg/kg) (mg/kg/min.)

















































































1/2 recovery at 300
1/2 recovery at 260
158
130
* Represents changes in Montevideo unit from pre-infusion values.
** Time following completion of diazoxide infusion.
Tab. 2. Effect of a bolus injection of diazoxide (6 mg/kg) on uterine activity (Group II).
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6 mg/kg, there was an almost immediate reduc-
tion of uterine activity, and complete suppression
within 8 minutes (tab. 2). The Inhibition was,
however, short-lived. Activity began to appear in
10 minutes and within 30 minutes or less it returned
to the pre-infusion level. In the third group of
animals where uterine activity was mild, and
diazoxide was infused very slowly in low con-
centration, the response was more gradual
(tab. 3). Uterine activity was suppressed by 50%
in approximately 30 minutes and reduced com-
pletely or to a very low level by one hour.
In the 10 control animals, uterine activity either
remained at the same level or increased s labor
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Fig. 2. Mean concentration of diazoxide in maternal and
fetal atterial blood following intravenous infusion of
diazoxide to the mother. The two upper cutves are from
3 experiments where the mother was given 60 mg/kg, and
the lower curves from 3 experiments with 6 mg/kg.
2.2 Placental transfer of diazoxide (fig. 2)
• f
Diazoxide readily crossed the placenta and after
60 minutes of infusion blood levels in the fetus
had reached 50% of that in the mother. The
level in maternal blood remained high for 60
minutes after completing the infusion, and
during this time the level of drug in fetal blood
continued to increase. Equilibrium between
mother and fetus was reached 60 minutes after
completing the infusion when 6 mg/kg were
given and in 120 minutes when 60 mg/kg were
given. In group III, when a dilute solution of
diazoxide was given over several hours, the con-
centrations of drug in both maternal and fetal
blood were similar and reached 10 mg per 100 ml
by six hours (B 108, B 124, B 411).
2.3 Maternal and fetal response to diazoxide
infusion
Blood Pressure and Heart Rate (tab. 5). Infusion
of diazoxide resulted in a fall in arterial blood
pressure and a rise in heart rate in both
mother and fetus. Hypotension was most pro-
nounced when a larger amount of the drug was
administered. Fetal hypotension was, in most
instances, proportionately greater than that seen
in the mother except when the drug was given
s a single bolus injection. The degree of maternal
tachycardia was also dose related. Although fetal
tachycardia occurred, the response was more
variable, due probably to fetal asphyxia following
Tab. 4. Group IV (Control Group) Acid-base and circulatory changes in the mother and fetus from the pre-infusion
values to the termmation of saline infusion.
Mother
Pre-infusion End of infusion
Fetus
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Alternating Pressure Respirator for
New-Born Babies (according to Saling)
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UPTO DATE WITH PERINATALMEDICINE
When reanimating asphyxia new-
borns a rapid insufflation of oxygen
is indicated. This can be done with
our alternating pressure respirator,
which helps you in treating hypoxia
and acidosis of newborns.
The respirator is called Wß 66 and
is built according to Prof, Saling.
It is easy and safe in its application-
much more so than the WB 58 from
which we developed it, The WB 66
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alternating pressure. The unit is
so handy that you may take it
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advantages. What eise is new with
the AUER WB 66 our technical
leaflet will teil you. Just mail us
the coupon.
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* Mcan artcrial blood prcssurc
** Observation continued for over 3 hours




















FETAL HEART l a
RATE
(BEATS/MIN) 120-
TIME FROM START 60-
OF INFUSION OF
PROSTAGLANDIN
100 105 HO 115
Diazoxide 6mg/kg i.v.
Fig. 3. EfTect of a single bolus injection of diazoxide on uterine activity induced with prostaglandin F2<x.
Note the immediate cessation of uterine activity and the onset of maternal hypotension and tachycardia followed
by the development of fetal hypotension and tachycardia with a lag time of 2 to 3 minutes.
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maternal and fetal hypotension. Changes in
maternal heart rate and blood pressure began
within a minute o£ diazoxide administration and
the corresponding changes in fetal cardiovascular
Status were seen 2—3 minutes later, reflecting the
rapid placental transfer. This was clearly demon-
strated in the experiments where a bolus of
diazoxide was given (fig. 3); it was also seen
when the drug was given äs a constant infusion
(fig. 1). Mild hypotension and tachycardia were
also seen in those animals receiving a prolonged
infusion at a low concentration (group III), but
the changes were not significant.
Recovery of maternal blood pressure and heart
rate was most rapid in those animals receiving
the drug äs a single bolus injection, occurring in
approximately 10 minutes (group II). In the animals
receiving a total dose of 6—12 mg/kg äs a
continuous infusion (group I) recovery rate
was much slower (30 to 120 minutes). When a
larger dose was given, hypotension and tachy-
cardia persisted for over three hours of observa-
tion, after the infusion had been completed.
Recovery of fetal blood pressure occurred slowly
even in the single injection group. In only one
fetus in group I, had it returned to the control
level after l hour of obsefvation. In those ex-
periments where the mother received a larger dose
of diazoxide, severe fetal hypotension persisted
throughout the period of observation.
The time during which fetal tachycardia per-
sisted after completing the infusion was variable.
In the bolus injection, group II, it remained for
60 minutes and in half of the animals in group I,
it was still present after 3 hours. Läte decelera-
tion of the fetal heart rate, which was seen in
3 animals in each of groups I and II, disappeared
when uterine activity was inhibited by infusion
of diazoxide (fig. 1).
2.4 Blood pH and gas tensions
Maternal acid-base state remained stable
during the Operation and recovery period. Mean
pre-infusion values were pH 7.42 ± 0.001 (S. E.),
Pco2 32 ± 11-5 mmHg, base deficit 3.2 ± 0.62
mEq/L, and PO2104 ± 10.9 mmHg. A slight meta-
bolic acidosis developed äs labor progressed but
this was compensated for by ä fall in Pco2·
Changes in fetal acid-base state are presented
in tab. 6. In those experiments where labor was
























































































































































































Significant, p < 0.01 ** Significant, p < 0.05
J. Perinat. Med. l (1973)
Morishima et ah, Inhibitory action of Diazoxidc on utcrinc activity 19
well-establishcd, varying degrees of fetal acid-
O818 wcrc prcsent at the cnd of the control
period (scc initial values groups I, II, and IV).
In group 111, where only mild contractions
occurred, acid-base statc rcmaincd normal.
Fetal acidosis incrcased significantly durlng
and following infusion of diaaoxide in group
I and II. A slight fall in pH was also
observcd in group III (low dosage) and group IV
(control) over the same timc intcrval, but these
changes were not significant. Fetal PO2 values
were normal in all but 2 animals at the end of
the control period. Infusion of diazoxide was
accompanied by a fall in PO2 which was signifi-
cant in group L Thus, despitc Inhibition of
utcrinc activity, PO2 feil in gcneral. A small
rise in fetal PO2 was actually observed in 3 ex-
periments, but was not of a sufficient order to
prevent progressive increase in fetal acidosis.
2.5 Blood glucose levels
Glucose concentrations in arterial blood were
measured in 14 cxperiments, all animals in group I,
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Fig. 4. Mean blood eugar levcls of mother and fetue
during and following infusion of diazoxide in 10 experi-
ments. S. E. — Standard Error.
infusion levels in mother and fetus were 53.7 i
2.52 and 49.2 ± 2.78 mg/100 ml, respectively.
There was a rapid increase in blood glucose
of both mother and fetue following administra-













Fig. 5. Mcan blood eugar levcls in mother and fctue
during prolongcd infusion of diaaoxidc at low conccntra-
tions (4 animals in group III).
30 minutes after completing the infusion. Hyper-
glyccmia pcrsisted for over 150 minutes. The
Standard errors were large because of diflferent
doses of diafcoxide. Glucose levels in fetal blood
were consistently lower than those in maternal
blood (fig. 4). When diazoxide was infused slowly
in a low conccntration (fig. 5), no hyperglycemic
responsc was observed in either mother or fetus
for over 4.5 hours. Thereafter, glucose levels
increased in a parallel fashion.
3. Discussion
The purpose of these experiments was to dcter-
mine the eflfect of diazoxide on the fetus. The
effectivenees of the drug in suppressing
uterine activity was confirmed, regardless of
whether labor was spontaneous or induced;
uterine contractions could be suppressed in in-
duced labor, even though the myometrial stimu-
lating agent, oxytocin or prostoglandin F2<x> was
continuously being infused. However, certain
adverse effects were noted. In order to suppress
well-established labor, the dose of diazoxide
required, also caused matemal hypotension.
The drug readily crossed the placenta and caused
fetal hypotension which persistcd in some cases.
for several hours, probably because the drug has.
a long half-life [14].
The bolus injection was most eßective in pro-
ducing an immediate cessation of uterine
activity but the action was of relatively short
duration and was associatcd with significant
J. Pctinat. Mcd, l (1973) 2*
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hypotension. Despite this adverse effect on the to that which developed during labor in some
fetus, the drug might prove to be very useful animals in our previous experiments. However,
for the emergency mänagement of tetanic with diazoxide infusion, the acidosis developed
uterine contractions. The drug was effective and more rapidly, 60 minutes äs compared to 120 to
without adverse effects on mother and fetus when 180 minutes in earlier experiments. Fürthermore,
given in low dosage over a prolonged period o£ the acidosis persisted despite the abolition of
time for the control of mild uterine coritrac- uterine contractions. It would appear, therefore,
v'tions. that the diazoxide administration to the mother
Diazoxide administration was followed by the was an important factor in the development of
development of acidosis and hypotension In fetal acidosis probably because of maternäl and
fetuses in groups I and II. The degree of acidosis fetal hypotension. Prolonged fetal hypotension due
which developed was significantly greater than to the long half-life of the drug is also likely
that seen in the control group in this series. It to have contributed to the persistence of the
might be argued that the fetal deterioration was acidosis, although uterine contractions have been
the result of the operative procedure and long abolished. More severe degrees of fetal asphyxia
observation period, rather than the action of the also cause hypotension. However, hypotension
drug itself on maternäl and fetal hemodynamics. seen in these experiments was of a more rapid
The stable condition of animals in group III, onset and of a much greater degree than observed
where only small doses of diazoxide were ad- in earlier experiments with a similar order
ministered over several hours, without the devel- of fetal acidosis [7].
opment of fetal hypotension or acidosis does not Maternäl blood glucose levels during the control
support such an Interpretation. Serial observations period (fig. 4) were within normal ränge [13] for
of acid-base state over a similar time period have rhesus monkeys; the fetal values were slightly
been made in 42 earlier experiments (tab. 7). elevated, äs a result of the mild acidosis and
Fetal acidosis did not develop if the Uterus hypoxia [4]. The hyperglycemic response in
remained quiescent. If labor began spontane- both mother and fetus was prompt and
ously or was artificially induced, some degree of sustained. No adverse effect of such hyperglycemia
acidosis developed in all fetuses, similar to that has been described for the adult. It is not known
seen in normal labor in humans. This was rela- whether or not prolonged hyperglyeemia in the
tively mild in those fetuses which were not fetus might have some untoward effect.
acidotic when uterine contractions began. Fetuses Our laboratory has in recent years conducted
which were more acidotic at the onset of similar experiments to examine the inhibitory
labor, probably äs a result of some compromise effect of both ethanol [6] and orciprenaline
in maternal-fetal perfusion of the intervillous space (Alupent®) [10] on the uterine activity in the
and fetal villi, became more severely acidotic subhuman primate. Diazoxide has been proven
äs labor progressed. The degree of acidosis seen to be the most effective of these three drugs in
in the present experiments in fetuses of group I suppressing both spontaneous or artificially
and II, whose mothers received relatively large induced labor. In particular it was the only
doses of diazoxide, was of a comparable degree drug which effectively stopped well-estab-
]. Perinat. Med. l (1973)
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lished spontaneous labor although all three
were effective if only mild contractions of early
labor were present. It was also the only drug
which suppressed artificially induced con-
tractions when given concommitantly with the
myometrial stimulating agent.
All three drugs had some adverse effects. The
dose of ethanol necessary to inhibit contractions
produced maternal respiratory depression, fetal
hypotension and acidosis. Örciprenaline re-
sulted in mild hypotension and tachycardia in
the mother, but quite marked fetal hypotension
and acidosis. While diazoxide was the most
efFective drug, it also caused the most severe
hypotension. Because of this, it cannot be
considered the ideal agent for suppressing
uterine activity. From our experiments, it would
seem that diazoxide is useful for emergency
management of tetanic contractions and in
low dosage for suppression of premature
labor. If employed, particular attention should
be paid to the monitoring of maternal blood
pressure and fetal heart rate. Should the fetus
be born even several hours after the drug has
been administered, the newborn may be hypo-
tensive.
Summary
The inhibiting action of diazoxide*, a benzothiadiazine
derivative, a smooth muscle relaxant on spontaneous and
induced labor, placental transfer of the drug and its
effect on the cardiovascular and biochemical state of
both mother and fetus has been studied in 31 subhuman
primates. Catheters were placed in the fetal carotid artery
or femoral artery and amniotic fluid at hysterotomy, and
in the maternal femoral artery and vein. In addition,
thermistor probes were placed in the fetal esophagus and
maternal rectum. Maternal and fetal arterial pressure, heart
rate, and amniotic fluid pressure were monitored and
recorded continuously. Following the operative procedure,
uterine contractions commenced spontaneously in 20 ani-
mals. In the remaining 11, uterine contractions were in-
duced with oxytocin or prostaglandin F2<x. Diazoxide was
infused intravenously into 21 animals while isotonic saline
was infused into the remaining 10, which formed a control
group. The drug was administered in three ways: (a) in a
graded dose to determine dose response, (b) äs a bolus
in an attempt to suppress uterine activity acutely, (c) in a
low dosage äs a slow, prolonged Infusion with only mild
uterine activity.
There was a reduction in the intensity of uterine activity
within a few minutes of commencing the diazoxide infusion
and \vithin 30 minutes there was a 50% suppression of
activity, irrespective of whether labor was spontaneous or
induced (fig. 1). Following the termination of diazoxide,
sustained Inhibition continued for 30 minutes or longer,
and in those animals receiving the largest dose, the in-
hibiting action lasted for over 2 hours (tabs. l to 3).
Diazoxide readily crossed the placenta and after 60
minutes of infusing the drug, blood levels in the fetus
had reached 50% of maternal level (fig. 2). Equilibrium
between mother and fetus was reached 60 minutes after
completing the infusion when 6 mg/kg were given and in
* Hyperstat® (Schering Corporation, USA).
120 minutes when 60 mg/kg were given. Infusion of
diazoxide resulted in a fall in arterial blood pressure
and a rise in heart rate in both mother and fetus
(tab. 4). Hypotension was most pronounced when a larger
amount of the drug was administered. Changes in maternal
heart rate and blood pressure began within a minute of
diazoxide administration and the corresponding changes in
fetal cardiovascular Status were seen 3—7 minutes later,
reflecting the rapid placental transfer (fig. 3). Recovery of
maternal blood pressure and heart rate was most rapid in
those animals receiving the drug äs a single bolus in-
jection. When a larger dose was given, hypotension and
tachycardia persisted for over three hours of observation,
after the infusion had been completed (tabs. 4 and 5).
Late deceleration of the fetal heart rate disappeared
when uterine activity was inhibited by infusion of diazoxide.
Maternal acid-base state remained stable throughout the
experiment (tab. 6); a slight metabolic acidosis developed
äs labor progressed but this was compensated for by a
fall in Pcx>2· Varying degrees of fetal acidosis were present
at the end of the control period in those experiments
where labor was weli-established. The degree of fetal
acidosis increased significantly during and following
infusion of diazoxide (tab. 7).
There was a rapid increase in blood glucose of both
mother and fetus following administration of diazoxide
which reached a plateau 30 minutes after completing the
infusion (figs. 4 and 5). Hyperglycemia persisted for over
150 minutes.
The efTectiveness of diazoxide in suppressing uterine
activity was confirmed, regardless of whether labor was
spontaneous or induced. Certain adverse effects were noted.
The dose required to suppress well-established labor
also caused maternal hypotension. The drug was efFective
and without adverse effects on mother and fetus when
en given in low dosage over a prolonged period of
time for the control of mild uterine contractions.
Keywords: Acid-base state, diazoxide, fetus, placental transfer, primate, oxytocin, prostaglandin, uterine activity.
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Zusammenfassung
Die Hemmwirkung von Diazoxide auf die Wehen-
tätigkeit beim subhumanen Primaten: Plazentarer
Transfer und Wirkung auf den Fetus
Die hemmende Wirkung von Diazoxide*, einem Benzo-
thiadiazidabkömmling mit relaxierender Wirkung auf die
glatte Muskulatur, auf spontane und induzierte Wehen-
tätigkeit sowie der plazentare Übertritt des Mittels und
seine Einwirkung auf den mütterlichen und fetalen
kardiovaskulären und biochemischen Status wurde an
31 subhumanen Primaten untersucht. Katheter wurden in
die A. carotis oder femoralis des Feten und in den liquor
amnii durch eine Hysterotomie eingeführt sowie in die
mütterliche A. und V. femoralis. Außerdem wurden Ther-
mistorsonden im Oesophagus des Feten und das Rektum
des Muttertieres plaziert. Arterielle Drucke von Fet und
Mutter, Pulsfrequenz und Liquordruck wurden fort-
laufend überwacht und registriert. Spontane Wehentätig-
keit begann bei 20 Tieren nach der Operation. Bei den
übrigen 11 Tieren wurde die Wehentätigkeit mit Oxytocin
\oder Prostglandin F2a angeregt. Diazoxide wurde 21 Tieren
intravenös infundiert; den restlichen 10 wurde als Kontroll-
gruppe physiologische Kochsalzlösung gegeben. Das Medi-
kament wurde in dreierlei Weise verabreicht: a) in abge-
stufter Dosierung, um die Dosisreaktion festzustellen;
b) in einem Bolus, in einem Versuch, die Uterusaktivität
akut zu unterdrücken; c) in niedriger Dosierung als lang-
same Infusion bei nur leichter Uterusaktivität.
Es erfolgte eine Herabsetzung der Intensität der Uterus-
aktivität innerhalb weniger Minuten nach Beginn der
Diazoxide-Infusion und nach 30 Minuten fand sich eine
50-prozentige Unterdrückung der Aktivität induzierter und
spontaner Wehentätigkeit (Abb. 1). Nach Beendigung der
Diazoxide-Infusion blieb die Hemmung für 30 Minuten
oder länger bestehen; bei den Tieren mit der höchsten
Dosis hielt die Hemmung über 2 Stunden an (Tab. l—3).
Diazoxide weist einen schnellen plazentaren Übertritt
auf, nach 60-minütiger Infusion betrugen die Konzentra-
tionen in den Feten 50% der mütterlichen Werte (Abb. 2).
Ein Gleichgewicht zwischen Mutter und Fet war 60 Minu-
* Hyperstat® (Schering Corporation, USA).
ten nach Beendigung der Infusion von 6 mg/kg und
120 Minuten nach einer Gabe von 60 mg/kg erreicht. Die
Diazoxide-Infusion führte zum Abfall des arteriellen
Blutdruckes und zum Anstieg der Herzfrequenz so-
wohl des Muttertieres als auch des Feten (Tab. 4). Die
Hypotension war am stärksten ausgeprägt nach höherer
Dosierung. Veränderungen des mütterlichen Pulses und
Blutdruckes begannen innerhalb einer Minute nach
Diazoxide; die entsprechenden fetalen Veränderungen wur-
den 2—3 Minuten später beobachtet, dem raschen Plazen-
tarübertritt entsprechend (Abb. 3). Die Normalisierung des
mütterlichen Pulses und Blutdruckes erfolgte am
schnellsten bei denjenigen Tieren, welche das Mittel in
einem einzigen Bolus erhalten hatten. Nach höherer Dosie-
rung bestanden Hypotension und Tachykardie für über
3 Stunden nach Beendigung der Infusion (Tab. 4 und 5).
Späte Dezelerationen der fetalen Herzfrequenz ver-
schwanden nach Hemmung der Uterusaktivität durch
Diazoxide. Der mütterliche Säure-Basen-Status blieb
stabil während des Experimentes (Tab. 6), eine leichte
metabolische Azidose, welche durch einen Abfall des PCO?
kompensiert wurde, erschien nach anhaltender Wehen-
tätigkeit. Unterschiedliche Ausmaße von fetaler Azidose
wurden am Ende der Kontrollperiode derjenigen Experi-
mente beobachtet, bei welchen aktive Wehentätigkeit be-
stand. Das Ausmaß der fetalen Azidose war signifikant
höher während und nach der Diazoxide-Infusion
(Tab. 7).
Ein rascher Anstieg des mütterlichen und fetalen Blut-
zuckers nach Diazoxide wurde beobachtet, welcher ein
Plateau 30 Minuten nach Beendigung der Infusion er-
reichte (Abb. 4 und 5). Die Hyperglykämie bestand für
über 150 Minuten.
Die Wirksamkeit des Diazoxide, Uterusaktivität zu
hemmen, wurde bestätigt, gleich ob bei spontaner oder
induzierter Wehentätigkeit. Gewisse ungünstige Neben-
wirkungen wurden beobachtet. Die nötwendige Dosis für
die Unterdrückung aktiver Wehen verursacht mütterliche
Hypotension. Das Medikament wat wirksam und ohne
ungünstige Nebenwirkungen auf Mutter und Fet wenn
es niedrig dosiert während eines längeren Zeitraumes
zur Hemmung leichter Wehentätigkeit gegeben wurde.
Schlüsselwörter: Säure-Basen-Status, Diazoxide, Fetus, Oxytocin, plazentarer Übertritt^ Primaten, Prostaglandin,
Uterusaktivität, Wehenhemmung.
Resume
L'action inhibitrice de la diazoxide* sur la contraction
uterine chez le singe primate: passage placentaire et
effet sur le foetus
L'effet de la Diazoxide (derive de la Benzothiazine a action
myorelaxante pour la fibre lisse) a eto etudie chez 31 singes
primates.
Hyperstat® (Schering Corporation, USA).
La drogue agit rapidement sur la contraction uterine
qui diminue de 50% en 30 minutes, qüe le travail soit
spontan6 ou induit (fig. 1). L'efFet dure 30 rninutes apres
la fin de la perfusion et jusqu'a 2 h en ca? de forte dose
(Tab. l ä 3).
La Diazoxide traverse facilement le placenta. Au bout
d'une heure de perfusion, le taux sanguin foetal a atteint
50% du taux rnaternel (fig. 2). L'equilibre entre les taux
J. Perinat. Med. l (1973)
Morishima et ah, Inhibitory action of Diazoxide on uterine activity 23
sanguins matcrnel et foetal est atteint en 60 minutes si la
perfusion est de 6 mg/kg, en 120 ou si la dose est de
120 mg/kg.
La Diazoxide entraine une hypotension arterielle et
une tachycardie chez la mfere et chez l'enfant (tab. 4).
II disparait vite en cas de dose unique injectoe rapi-
dement; plus lentement (jusqu'ä trois heures) en cas de
dose importante (tab. 4 et 5). Des ralentissements tardifs
du rythme cardiaque foetal disparaissent lorsque la
contraction est bloquee par la Diazoxide. L'£quilibre
acido basique teste inchang£ chez la m& e (tab. 6)
tandis que, se doveloppe une legere acidose foetale,
compensoe par une baisse de la Pco2> ma^s qul cr°fr tout
au long et apras la perfusion (tab. 7). II se produit une
hyperglycomie maternelle et foetale, maxima, puis au bout
de 30 minutes (fig. 4 et 5), puis en plateau pendant
150 minutes.
II se confirme donc que la Diazoxide est capable de
bloquer les contractions ut£rines, spontanoes ou provo-
qudes; la dose efficace entraine des effets secondaires,
notamment une hypotension maternelle. Administrae ä
faible dose et assez longtemps, eile est en revanche
efficace, sans effet nocif maternel ou foetal, pour stopper
des contractions utorines d'intensitd moyenne.
Mots-des: Acide base, Diazoxide, Foetus, Ocytocine, Passage placentaire, Primate, Prostaglandine, Contraction utorine.
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